(FSTR) LB Foster - Overview
Stock: Rail, Infrastructure, Concrete, Steel, Coatings
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 38.1% |
| Relative Tail Risk | -7.33% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.38 |
| Alpha | -6.75 |
| Character TTM | |
|---|---|
| Beta | 1.194 |
| Beta Downside | 0.960 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.90% |
| CAGR/Max DD | 0.83 |
Description: FSTR LB Foster December 31, 2025
L.B. Foster Company (NASDAQ:FSTR) designs, manufactures, and services engineered products that support rail and broader infrastructure projects across North America, the United Kingdom, and other international markets. The business is split into two segments: (1) Rail, Technologies & Services, which supplies new and used rail, track accessories, engineered concrete ties, friction-management systems, and condition-monitoring equipment; and (2) Infrastructure Solutions, which produces precast concrete structures (e.g., restrooms, concession stands, sound walls), steel bridge components, corrosion-protection treatments, and pipeline-coating services. The firm was founded in 1902 and is headquartered in Pittsburgh, Pennsylvania.
According to the most recent Form 10-K (FY 2023), FSTR generated approximately $1.2 billion in revenue, with an EBITDA margin around 10 % and a backlog of roughly $500 million, indicating a solid pipeline of long-term contracts. The company’s exposure to U.S. rail-infrastructure spending is a key driver; the 2021 Infrastructure Investment and Jobs Act is projected to add $110 billion in rail-related capital over the next decade, potentially boosting demand for both new-rail products and monitoring services. Additionally, the precast concrete segment benefits from municipal funding cycles, which tend to be counter-cyclical to broader construction activity, providing a partial hedge against rail-sector volatility.
For a deeper quantitative dive into FSTR’s valuation metrics and scenario analysis, you may find the ValueRay platform useful.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 4.89m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 5.27 > 1.0 |
| NWC/Revenue: 16.54% < 20% (prev 18.06%; Δ -1.52% < -1%) |
| CFO/TA 0.11 > 3% & CFO 37.7m > Net Income 4.89m |
| Net Debt (80.9m) to EBITDA (29.0m): 2.79 < 3 |
| Current Ratio: 2.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (10.9m) vs 12m ago -1.02% < -2% |
| Gross Margin: 21.81% > 18% (prev 0.22%; Δ 2158 % > 0.5%) |
| Asset Turnover: 149.7% > 50% (prev 156.0%; Δ -6.29% > 0%) |
| Interest Coverage Ratio: 3.27 > 6 (EBITDA TTM 29.0m / Interest Expense TTM 4.90m) |
Altman Z'' 4.66
| A: 0.25 (Total Current Assets 153.5m - Total Current Liabilities 69.5m) / Total Assets 333.9m |
| B: 0.52 (Retained Earnings 172.7m / Total Assets 333.9m) |
| C: 0.05 (EBIT TTM 16.0m / Avg Total Assets 339.2m) |
| D: 0.96 (Book Value of Equity 152.1m / Total Liabilities 158.3m) |
| Altman-Z'' Score: 4.66 = AA |
Beneish M -3.31
| DSRI: 0.88 (Receivables 72.4m/86.9m, Revenue 507.8m/537.5m) |
| GMI: 1.01 (GM 21.81% / 22.05%) |
| AQI: 0.91 (AQ_t 0.22 / AQ_t-1 0.24) |
| SGI: 0.94 (Revenue 507.8m / 537.5m) |
| TATA: -0.10 (NI 4.89m - CFO 37.7m) / TA 333.9m) |
| Beneish M-Score: -3.31 (Cap -4..+1) = AA |
What is the price of FSTR shares?
Over the past week, the price has changed by +5.62%, over one month by +14.92%, over three months by +16.26% and over the past year by +11.96%.
Is FSTR a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FSTR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29 | -8.6% |
| Analysts Target Price | 29 | -8.6% |
| ValueRay Target Price | 38.9 | 22.7% |
FSTR Fundamental Data Overview February 04, 2026
P/E Forward = 12.9366
P/S = 0.6488
P/B = 1.7867
P/EG = 0.1523
Revenue TTM = 507.8m USD
EBIT TTM = 16.0m USD
EBITDA TTM = 29.0m USD
Long Term Debt = 58.6m USD (from longTermDebt, last quarter)
Short Term Debt = 167.0k USD (from shortTermDebt, last quarter)
Debt = 84.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 80.9m USD (from netDebt column, last quarter)
Enterprise Value = 410.4m USD (329.5m + Debt 84.4m - CCE 3.51m)
Interest Coverage Ratio = 3.27 (Ebit TTM 16.0m / Interest Expense TTM 4.90m)
EV/FCF = 14.81x (Enterprise Value 410.4m / FCF TTM 27.7m)
FCF Yield = 6.75% (FCF TTM 27.7m / Enterprise Value 410.4m)
FCF Margin = 5.46% (FCF TTM 27.7m / Revenue TTM 507.8m)
Net Margin = 0.96% (Net Income TTM 4.89m / Revenue TTM 507.8m)
Gross Margin = 21.81% ((Revenue TTM 507.8m - Cost of Revenue TTM 397.1m) / Revenue TTM)
Gross Margin QoQ = 22.47% (prev 21.52%)
Tobins Q-Ratio = 1.23 (Enterprise Value 410.4m / Total Assets 333.9m)
Interest Expense / Debt = 1.49% (Interest Expense 1.25m / Debt 84.4m)
Taxrate = 39.40% (2.81m / 7.14m)
NOPAT = 9.70m (EBIT 16.0m * (1 - 39.40%))
Current Ratio = 2.21 (Total Current Assets 153.5m / Total Current Liabilities 69.5m)
Debt / Equity = 0.48 (Debt 84.4m / totalStockholderEquity, last quarter 174.8m)
Debt / EBITDA = 2.79 (Net Debt 80.9m / EBITDA 29.0m)
Debt / FCF = 2.92 (Net Debt 80.9m / FCF TTM 27.7m)
Total Stockholder Equity = 174.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.44% (Net Income 4.89m / Total Assets 333.9m)
RoE = 2.80% (Net Income TTM 4.89m / Total Stockholder Equity 174.6m)
RoCE = 6.87% (EBIT 16.0m / Capital Employed (Equity 174.6m + L.T.Debt 58.6m))
RoIC = 4.01% (NOPAT 9.70m / Invested Capital 242.0m)
WACC = 8.39% (E(329.5m)/V(413.9m) * Re(10.31%) + D(84.4m)/V(413.9m) * Rd(1.49%) * (1-Tc(0.39)))
Discount Rate = 10.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.50%
[DCF Debug] Terminal Value 68.46% ; FCFF base≈20.8m ; Y1≈13.7m ; Y5≈6.23m
Fair Price DCF = 3.18 (EV 114.0m - Net Debt 80.9m = Equity 33.1m / Shares 10.4m; r=8.39% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 29.38 | EPS CAGR: 1.00% | SUE: -0.63 | # QB: 0
Revenue Correlation: 26.59 | Revenue CAGR: 5.54% | SUE: -2.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.07 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.76 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+55.5% | Growth Revenue=+2.7%